Stephanie Lovell

Insider Reports History

Location
Cambridge, MA
Signature
By: /s/ Gerardo Hernandez, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephanie Lovell:

Company Role Class Num Shares Value Price $ Report Date Ownership
TransMedics Group, Inc. Director Common Stock 2,866 $428,810 $149.62 04 Mar 2026 Direct
Cyclerion Therapeutics, Inc. Director Stock Option (Right to Buy) 20,000 14 Jun 2022 Direct

Insider Reports Filed by Stephanie Lovell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TMDX TransMedics Group, Inc. 04 Mar 2026 1 -$178,497 4 Director 06 Mar 2026, 18:12
TMDX TransMedics Group, Inc. 22 May 2025 1 $0 4 Director 23 May 2025, 18:48
TMDX TransMedics Group, Inc. 23 May 2024 2 $0 4 Director 28 May 2024, 17:30
TMDX TransMedics Group, Inc. 25 May 2023 2 $0 4 Director 30 May 2023, 16:30
TMDX TransMedics Group, Inc. 22 Nov 2022 9 -$139,602 4 Director 23 Nov 2022, 15:30
CYCN Cyclerion Therapeutics, Inc. 14 Jun 2022 1 $0 4 Director 16 Jun 2022, 20:56
TMDX TransMedics Group, Inc. 01 Jun 2022 1 $0 4 Director 06 Jun 2022, 16:29
CYCN Cyclerion Therapeutics, Inc. 24 Jun 2021 1 $0 4 Director 28 Jun 2021, 17:27
TMDX TransMedics Group, Inc. 27 May 2021 1 $0 4 Director 01 Jun 2021, 17:20